Is overall blockade superior to selective blockade of adrenergic receptor subtypes in suppressing left ventricular remodeling in spontaneously hypertensive rats

Hypertension Research

Volumn 33, Issue 10, 2010, Pages 1071-1081

  Chen, Wen Qiang ^a   Cai, Heng ^b   Zhang, Cheng ^a   Ji, Xiao Ping ^a   Zhang, Yun ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

adrenergic receptor subtype; left ventricular remodeling; spontaneously hypertensive rat

Indexed keywords

ALPHA 1B ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BISOPROLOL; CALCIUM; CARVEDILOL; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CYCLIC AMP DEPENDENT PROTEIN KINASE; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PROPRANOLOL; PROTEIN KINASE C ALPHA; PROTEIN KINASE C DELTA;

ADRENERGIC RECEPTOR BLOCKING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIHYPERTENSIVE THERAPY; APOPTOSIS; ARTICLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CALCIUM CELL LEVEL; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SELECTIVITY; ECHOCARDIOGRAPHY; FLOW CYTOMETRY; GENE EXPRESSION; HEART CATHETERIZATION; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE PRESSURE; HEART LEFT VENTRICLE RELAXATION; HEART MUSCLE CELL; HEART RATE; HEART VENTRICLE REMODELING; HISTOPATHOLOGY; HYPERTENSION; IMMUNOHISTOCHEMISTRY; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; WESTERN BLOTTING; WISTAR KYOTO RAT;

ADRENERGIC ANTAGONISTS; ANIMALS; APOPTOSIS; BISOPROLOL; BLOOD PRESSURE; CARBAZOLES; DISEASE MODELS, ANIMAL; HEART RATE; HUMANS; HYPERTENSION; MYOCYTES, CARDIAC; PROPANOLAMINES; PROPRANOLOL; RATS; RATS, INBRED SHR; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ADRENERGIC, BETA; VENTRICULAR REMODELING;

EID: 77957713414     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2010.121     Document Type: Article

References (48)

1. Asai T, Kushiro T, Fujita H, Kanmatsuse K. Different effects on inhibition of cardiac hypertrophy in spontaneously hypertensive rats by monotherapy and combination therapy of adrenergic receptor antagonists and/or the angiotensin II type 1 receptor blocker under comparable blood pressure reduction. Hypertens Res 2005; 28: 79-87.
2. Sever P. New Hypertension Guidelines from the National Institute for Health and Clinical Excellence and the British Hypertension Society. J Renin Angiotensin Aldos-terone Syst 2006; 7: 61-63.
3. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clément D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heagerty A, Kjeldsen SE, Kiowski W, Mallion JM, Manolis A, Narkiewicz K, Nilsson P, Olsen MH, Rahn KH, Redon J, Rodicio J, Ruilope L, Schmieder RE, Struijker-Boudier HA, van Zwieten PA, Viigimaa M, Zanchetti A. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009; 27: 2121-2158.
4. i-mediated signaling. Circulation 2005; 112: 1145-1153.
5. Yamazaki T, Komuro I, Zou Y, Kudoh S, Shiojima I, Hiroi Y, Mizuno T, Aikawa R, Takano H, Yazaki Y. Norepinephrine induces the raf-1 kinase/mitogen-activated protein kinase cascade through both alpha 1-and beta-adrenoceptors. Circulation 1997; 95: 1260-1268.
6. Asai K, Yang GP, Geng YJ, Takagi G, Bishop S, Ishikawa Y, Shannon RP, Wagner TE, Vatner DE, Homcy CJ, Vatner SF. Beta-adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic G(salpha) mouse. J Clin Invest 1999; 104: 551-558.
7. Iwata M, Yoshikawa T, Baba A, Anzai T, Nakamura I, Wainai Y, Takahashi T, Ogawa S. Autoimmunity against the second extracellular loop of beta(1)-adrenergic receptors induces beta-adrenergic receptor desensitization and myocardial hypertrophy in vivo. Circ Res 2001; 88: 578-586.
8. Mougenot N, Mediani O, Lechat P. Bisoprolol and hydrochlorothiazide effects on cardiovascular remodeling in spontaneously hypertensive rats. Pharmacol Res 2005; 51: 359-365.
9. 1-selectivity and favourable pharmacokinetics as the outstanding properties of bisoprolol. J Cardiovasc Pharmacol 1986; 8: S2-S15.
10. Yaoita H, Sakabe A, Maehara K, Maruyama Y Different effects of carvedilol, metoprolol and propranolol on left ventricular remodeling after coronary stenosis or after permanent coronary occlusion in rats. Circulation 2002; 105: 975-980.
11. Devereux RB. Detection of left ventricular hypertrophy by M-mode echocardiography. Anatomic validation, standardization, and comparison to other methods. Hypertension 1987; 9: II9-I26.
12. Weiss JL, Frederiksen JW, Weisfeldt ML. Hemodynamic determinants of the time-course of fall in canine left ventricular pressure. J Clin Invest 1976; 58: 751-760.
13. Mandarim-de-Lacerda CA. Stereological tools in biomedical research. An Acad Bras Cienc 2003; 75: 469-486.
14. Login GR, Ku TC, Dvorak AM. Rapid primary microwave-aldehyde and microwave-osmium fixation: improved detection of rat parotid acinar cell secretory granule alpha-amylase using a post-embedding immunogold ultrastructural morphometric analysis. J Histochem Cytochem 1995; 43: 515-523.
15. Brette F, Salle L, Orchard CH. Quantification of calcium entry at the T-tubules and surface membrane in rat ventricular myocytes. Biophys J 2006; 90: 381-389.
16. Oyama Y, Chikahisa L, Kanemaru K, Nakata M, Noguchi S, Nagano T, Okazaki E, Hirata A. Cytotoxic actions of FTY720, a novel immunosuppressant, on tyhmocytes and brain neurons dissociated from the rat. JPN J Pharmacol 1998; 76: 377-385.
17. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001; 25: 402-408.
18. Weiss RJ, Rauscher A, ShawD. Effect of bisoprolol and atenolol on left ventricular mass in patients with essential hypertension. Am J Ther 1994; 1: 81-85.
19. Onodera T, Okazaki F, Miyazaki H, Minami S, Ito T, Seki S, Taniguchi M, Taniguchi I, Mochizuki S. Perindopril reverses myocyte remodeling in the hypertensive heart. Hypertens Res 2002; 25: 85-90.
20. Saragoca MA, Cezaretti ML, Tavares A, Bessa AM, Almeida JB, Amorin MP, Ramos OL. Pindolol, not propranolol, reverses cardiac hypertrophy in renal hypertensive rats. Hypertension 1988; 11: I89-I92.
21. Pacca SR, de Azevedo AP, De Oliveira CF, De Luca IM, De Nucci G, Antunes E. Attenuation of hypertension, cardiomyocyte hypertrophy, and myocardial fibrosis by beta-adrenoceptor blockers in rats under long-term blockade of nitric oxide synthesis. J Cardiovasc Pharmacol 2002; 39: 201-207.
22. Carreira RS, Monteiro P, Gon Alves LM, Providencia LA. Carvedilol: just another beta-blocker or a powerful cardioprotector? Cardiovasc Hematol Disord Drug Targets 2006; 6: 257-266.
23. Brodde OE, Michel MC. Adrenergic and muscarinic receptors in the human heart. Pharmacol Rev 1999; 51: 651-690.
24. Cava ll i A, Lattion AL, Hummler E, Nenniger M, Pedrazzini T, Aubert JF Decreased blood pressure response in mice deficient of the a 1B-adrenergic receptor. Proc Natl Acad Sci USA 1997; 94: 11589-11594.
25. 1B-adrenergic receptors after pressure overload in mouse hearts. Am J Physiol Heart Circ Physiol 2000; 279: H1079-H1086.
26. Vecchione C, Fratta L, Rizzoni D, Notte A, Poulet R, Porteri E, Frati G, Guelfi D, Trimarco V, Mulvany MJ, Agabiti-Rosei E, Trimarco B, Cotecchia S, Lembo G. Cardiovascular influences of alpha1b-adrenergic receptor defect in mice. Circulation 2002; 105: 1700-1707.
27. 1B-and a1D-adrenoceptor subtypes. JPET 2003; 305: 1045-1053.
28. 2+. Alcohol 2000; 21: 149-159.
29. Witte K, Parsa-Parsi R, Vobig M, Lemmer B. Mechanisms of the circadian regulation of beta-adrenoceptor density and adenylyl cyclase activity in cardiac tissue from normotensive and spontaneously hypertensive rats. J Mol Cell Cardiol 1995; 27: 1195-1202.
30. Atkins FL, Bing OH, DiMauro PG, Conrad CH, Robinson KG, Brooks WW. Modulation of left and right ventricular beta-adrenergic receptors from spontaneously hypertensive rats with left ventricular hypertrophy and failure. Hypertension 1995; 26: 78-82.
31. K-Laflamme A, Oster L, Cardinal R, de Champlain J. Effects of renin-angiotensin blockade on sympathetic reactivity and beta-adrenergic pathway in the spontaneously hypertensive rat. Hypertension 1997; 30: 278-287.
32. Chruscinski A, Brede ME, Meinel L, Lohse MJ, Kobilka BK, Hein L. Differential distribution of beta-adrenergic receptor subtypes in blood vessels of knockout mice lacking beta(1)-or beta(2)-adrenergic receptors. Mol Pharmacol 2001; 60: 955-962.
33. Bohm M, Ettelbruck S, Flesch M, van Gilst WH, Knorr A, Maack C, Pinto YM, Paul M, Teisman AC, Zolk O. Beta-adrenergic signal transduction following carvedilol treatment in hypertensive cardiac hypertrophy. Cardiovasc Res 1998; 40: 146-155.
34. Hirota H, Chen J, Betz UA, Rajewsky K, Gu Y, Ross Jr J, Müller W, Chien KR. Loss of a gp 130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell 1999; 97: 189-198.
35. Communal C, Singh K, Pimentel DR, Collucci WS. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the b-adrenergic pathway. Circulation 1998; 98: 1329-1334.
36. Wettschureck N, Offermanns S. Mammalian G proteins and their cell type specific functions. Physiol Rev 2005; 85: 1159-1204.
37. Kawamura S, Yoshida K, Miura T, Mizukami Y, Matsuzaki M. Ischemic preconditioning translocates PKC-delta and-epsilon, which mediate functional protection in isolated rat heart. Am J Physiol 1998; 275: H2266-H2271.
38. Dempsey EC, Newton AC, Mochly-Rosen D, Fields AP, Reyland ME, Insel PA, Messing RO. Protein kinase C isozymes and the regulation of diverse cell responses. Am J Physiol Lung Cell Mol Physiol 2000; 279: L429-L438.
39. Mackay K, Mochly-Rosen D. Localization, anchoring, and functions of protein kinase C isozymes in the heart. J Mol Cell Cardiol. 2001; 33: 1301-1307.
40. Molnár A, Borbély A, Czuriga D, Ivetta SM, Szilágyi S, Hertelendi Z, Pásztor ET, Balogh A, Galajda Z, Szerafin T, Jaquet K, Papp Z, Edes I, Tóth A. kinase C contributes to the maintenance of contractile force in human ventricular cardiomyocytes. J Biol Chem 2009; 284: 1031-1039.
41. 2+ channel. Circ Res 2008; 102: 1378-1388.
42. Zhu M, Gach AA, Liu G, Xu X, Lim CC, Zhang JX, Mao L, Chuprun K, Koch WJ, Liao R, Koren G, Blaxall BC, Mende U. Enhanced calcium cycling and contractile function in transgenic hearts expressing constitutively active G alpha o* protein. Am J Physiol Heart Circ Physiol 2008; 294: H1335-H1347.
43. Keys JR, Greene EA, Koch WJ, Eckhart AD. Gq-coupled receptor agonists mediate cardiac hypertrophy via the vasculature. Hypertension 2002; 40: 660-666.
44. Zaugg M, Xu W, Lucchinetti E, Shafiq SA, Jamali NZ, Siddiqui MAQ. Adrenergic receptor subtypes differentially affect apoptosis in adult rat ventricular myocytes. Circulation 2000; 102: 344-350.
45. Reiken S, Wehrens XH, Vest JA, Barbone A, Klotz S, Mancini D, Burkhoff D, Marks AR. Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure. Circulation 2003; 107: 2459-2466.
46. Shizukuda Y, Buttrick PM, Geenen DL, Borczuk AC, Kitsis RN, Sonnenblick EH. Beta-adrenergic stimulation causes cardiocyte apoptosis: influence of tachycardia and hypertrophy. Am J Physiol. 1998; 275: H961-H968.
47. Geng YJ, Ishikawa Y, Vatner DE, Wagner TE, Bishop SP, Vatner SF, Homcy CJ. Apoptosis in cardiac myocytes in Gsa transgenic mice. Circ Res. 1999; 84: 34-42.
48. Adams JW, Sakata Y, Davis MG, Sah VP, Wang Y, Liggett SB, Chien KR, Brown JH, Dorn II GW. Enhanced Gaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proc Natl Acad Sci USA 1998; 95: 10140-10145.